If you are altering the chemistry of the compound, ie., making it more potent -- as would be their intention with the pharma grade compound -- then you are starting over again with something entirely new. I believe your interpretations are, simply, more wishful thinking.
Ps. Whenever a small, fledgeling biotech projects the time frame studies should be completed by, you should probably double it. That is closer to reality.